These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 34176164)
1. Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils. Dauer Née Joppe K; Tatenhorst L; Caldi Gomes L; Zhang S; Parvaz M; Carboni E; Roser AE; El DeBakey H; Bähr M; Vogel-Mikuš K; Wang Ip C; Becker S; Zweckstetter M; Lingor P J Neurochem; 2021 Nov; 159(3):554-573. PubMed ID: 34176164 [TBL] [Abstract][Full Text] [Related]
2. Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein. Howe JW; Sortwell CE; Duffy MF; Kemp CJ; Russell CP; Kubik M; Patel P; Luk KC; El-Agnaf OMA; Patterson JR Parkinsonism Relat Disord; 2021 Aug; 89():41-47. PubMed ID: 34218047 [TBL] [Abstract][Full Text] [Related]
3. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein. Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656 [TBL] [Abstract][Full Text] [Related]
4. PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Thomsen MB; Ferreira SA; Schacht AC; Jacobsen J; Simonsen M; Betzer C; Jensen PH; Brooks DJ; Landau AM; Romero-Ramos M Neurobiol Dis; 2021 Feb; 149():105229. PubMed ID: 33352233 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation. Tavassoly O; Del Cid Pellitero E; Larroquette F; Cai E; Thomas RA; Soubannier V; Luo W; Durcan TM; Fon EA Neurotherapeutics; 2021 Apr; 18(2):979-997. PubMed ID: 33713002 [TBL] [Abstract][Full Text] [Related]
6. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy. Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665 [TBL] [Abstract][Full Text] [Related]
7. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils. Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792 [TBL] [Abstract][Full Text] [Related]
8. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy? De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639 [TBL] [Abstract][Full Text] [Related]
9. Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils. Roux A; Wang X; Becker K; Ma J J Parkinsons Dis; 2020; 10(4):1397-1410. PubMed ID: 32716318 [TBL] [Abstract][Full Text] [Related]
12. Novel naturally occurring autoantibodies attenuate α-synuclein pathology in a mouse model of Parkinson's disease. Li Y; Wang T; Meng L; Jin L; Liu C; Liang Y; Ren L; Liu Y; Liu Y; Liu S; Li T; Liang Y; Chen X; Zhang Z Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12860. PubMed ID: 36331758 [TBL] [Abstract][Full Text] [Related]
13. Iron reduces the propagation of pathological α-synuclein: An Editorial Highlight for "Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils" on page 554. Guo YJ; Ayton S; Lei P J Neurochem; 2021 Nov; 159(3):414-416. PubMed ID: 34296424 [TBL] [Abstract][Full Text] [Related]
14. Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions. Liu D; Guo JJ; Su JH; Svanbergsson A; Yuan L; Haikal C; Li W; Gouras G; Li JY Transl Neurodegener; 2021 Jun; 10(1):20. PubMed ID: 34148543 [TBL] [Abstract][Full Text] [Related]
16. Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain. Yabuki Y; Matsuo K; Kawahata I; Fukui N; Mizobata T; Kawata Y; Owada Y; Shioda N; Fukunaga K Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210174 [TBL] [Abstract][Full Text] [Related]
17. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice. Earls RH; Menees KB; Chung J; Barber J; Gutekunst CA; Hazim MG; Lee JK J Neuroinflammation; 2019 Dec; 16(1):250. PubMed ID: 31796095 [TBL] [Abstract][Full Text] [Related]
18. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy. Chatterjee D; Sanchez DS; Quansah E; Rey NL; George S; Becker K; Madaj Z; Steiner JA; Ma J; Escobar Galvis ML; Kordower JH; Brundin P J Parkinsons Dis; 2019; 9(2):315-326. PubMed ID: 30932894 [TBL] [Abstract][Full Text] [Related]
19. Cerebral Microvascular Injury Induced by Lag3-Dependent α-Synuclein Fibril Endocytosis Exacerbates Cognitive Impairment in a Mouse Model of α-Synucleinopathies. Zhang Q; Duan Q; Gao Y; He P; Huang R; Huang H; Li Y; Ma G; Zhang Y; Nie K; Wang L Adv Sci (Weinh); 2023 Sep; 10(25):e2301903. PubMed ID: 37381656 [TBL] [Abstract][Full Text] [Related]